{
    "case_number": "CAC-UDRP-107466",
    "time_of_filling": "2025-12-19 11:01:26",
    "domain_names": [
        "schizophreniauzedyrisperidonetreatment.online"
    ],
    "case_administrator": "  Iveta Špiclová   (Czech Arbitration Court) (Case admin)",
    "complainant": [
        "Teva Pharmaceutical Industries Ltd",
        "Teva Pharmaceuticals Usa, Inc",
        "Teva Pharmaceuticals International GmbH"
    ],
    "complainant_representative": "SILKA AB",
    "respondent": [
        "NC - WPH Online"
    ],
    "respondent_representative": null,
    "factual_background": "<p>The Complainant states that it is a leading and internationally recognized pharmaceutical company with a wide range of products distributed worldwide and used by an estimated 200 million people on a daily basis. Among others, the Complainant manufactures and commercializes \"Uzedy\", an atypical antipsychotic risperidone indicated for the treatment of schizophrenia in adults.<\/p>\n<p>The Complainant further states that it is the owner of the well-known trademark &ldquo;UZEDY&rdquo; since the early 00's and of various domain names, such as the domain name &lt;uzedy.com&gt;.<\/p>\n<p>The disputed domain name was registered on February 20, 2025 and it currently resolves to a parking page with third-party commercial links.<\/p>",
    "other_legal_proceedings": "<p>The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>",
    "no_response_filed": "<p>No administratively compliant Response has been filed.<\/p>",
    "rights": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>",
    "no_rights_or_legitimate_interests": "<p>The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>",
    "bad_faith": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>",
    "procedural_factors": "<p>The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>",
    "decision": "Accepted",
    "panelists": [
        "Tommaso La Scala"
    ],
    "date_of_panel_decision": "2026-01-25 00:00:00",
    "informal_english_translation": "<p>The Complainant is the owner of several national and international trademark registrations for &ldquo;UZEDY&rdquo;, including:<\/p>\n<ul>\n<li>\n<p>US Trademark Registration no. 7213994 UZEDY, registered on November 7, 2023, in international class 5;<\/p>\n<\/li>\n<li>\n<p>EUTM Registration no. 018537143 UZEDY, registered on April 28, 2022, in international class 5;<\/p>\n<\/li>\n<li>\n<p>Swiss Trademark Registration no. 793437 UZEDY, registered on February 17, 2023, in international class 5.<\/p>\n<\/li>\n<\/ul>\n<p>The Complainant also owns the domain names &lt;uzedy.com&gt; and &lt;uzedyhcp.com&gt; since 2021.<\/p>",
    "decision_domains": {
        "schizophreniauzedyrisperidonetreatment.online": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}